Receive our newsletter – data, insights and analysis delivered to you
  1. Special Focus
  2. Covid-19
February 11, 2021

Could a ‘Global Bio Force’ protect the world from future pandemics?

By Paul Dennis

11 February

Adrian Saville, the founder and CEO of Cannon Asset Managers, retweeted an article on the Covid-19 crisis, with genomic surveillance appearing to offer a way out of it.

Francis deSouza, an economist, argues that continuous genetic monitoring of viruses and mutations can tackle the Covid-19 crisis and also prevent another pandemic.

He writes that a similar revolution, like that of cybersecurity surveillance, needs to happen.

Therefore, a global Bio Force comprising private and government partnerships needs to be created to tackle the growing SARS-CoV-2 virus mutations, as well as to protect the world from future pandemics, bioterrorism, antimicrobial resistance, and others.

An effective Bio Force will collaborate with countries, research institutes, companies, and international bodies, to advance the genomics sector.

Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

The need is urgent, and while whole genome sequencing of pathogens is rapid, scalable, and cost-effective, it can be used as a radar to spot viral threats, experts opine.

Read more

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy